Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ATCOR
Naperville, Illinois, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
ATCOR is a cardiovascular health technology and medical device business focused on noninvasive vascular biomarker measurement, especially central blood pressure and arterial stiffness. Its core commercial franchise is the FDA-cleared and patented SphygmoCor technology, which is used in specialist care, hospital networks, clinical research, and pharmaceutical clinical trials. The company markets devices such as SphygmoCor XCEL and supports partner-enabled products including Oscar 2 with SphygmoCor inside. ATCOR also extends its technology into digital biomarker and wearable applications through ATCOR·X. Today, ATCOR operates as a healthcare brand/division within CardieX rather than as a separately listed standalone public company.
- Therapeutic areas
- NephrologyWomen's HealthEndocrinologyCardiovascularNeurologyPulmonologyOncology
- Modalities
- DeviceSoftware as a medical device
- Industry
- Physiological Monitoring
02
Partnerships
SunTech MedicalClinichainPharmaceutical companies using SphygmoCor in clinical trials
Beyond the preview
Go deeper on ATCOR.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ATCOR.